Also, it has been reported that applying LOXL1-AS1 siRNA-loaded exosomes can be considered as novel strategy for LOXL1-AS1 gene therapy in this type of cancer that leads to inhibit cancer progression and metastasis of medulloblastoma (107). Here, LOXL1 is linked to medulloblastoma.